Pricing Log in Create free account

Tenax Therapeutics, Inc. (TENX) vs Xilio Therapeutics, Inc. (XLO)

Tenax Therapeutics, Inc. and Xilio Therapeutics, Inc. are both Biotechnology companies. Tenax Therapeutics, Inc. and Xilio Therapeutics, Inc. are of similar size ($59.4M and $56.5M). Xilio Therapeutics, Inc. grew revenue faster over the last twelve months: 327.3% against −70.8%. Tenax Therapeutics, Inc. has the higher net margin (0.00% vs −34.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Xilio Therapeutics, Inc. leads on 8 and Tenax Therapeutics, Inc. on 7.

Valuation

Metric TENX XLO Biotechnology median
P/E n/m n/m 8.50
P/S 201.11 2.66 9.71
P/B 0.61 2.36 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.71 n/m 0.64
EV/Sales (141.75) 0.56 9.21
Earnings yield (108.82%) (17.00%) (33.15%)
Free cash flow yield (66.58%) (36.00%) (25.50%)

Profitability

Metric TENX XLO Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (48.94%) 0.00%
Net margin 0.00% (34.06%) 0.00%
Free cash flow margin 0.00% (95.59%) 0.00%
Return on equity (59.80%) (55.03%) (56.36%)
Return on assets (57.02%) (15.16%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric TENX XLO Biotechnology median
Revenue growth (TTM) (70.77%) 327.25% 6.02%
EPS growth (last fiscal year) (16.52%) 72.55% 30.26%
Revenue growth, 5-year CAGR 0.79% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric TENX XLO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 15.07 4.25 4.72
Net debt to EBITDA 1.73 3.40 0.96

Dividend

Metric TENX XLO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric TENX XLO Biotechnology median
Market cap 56.51m 59.35m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack